Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ovid Therapeutics (OVID) Non-Current Debt (2020)

Ovid Therapeutics (OVID) has disclosed Non-Current Debt for 1 consecutive years, with $61200.0 as the latest value for Q4 2020.

  • For the quarter ending Q4 2020, Non-Current Debt changed N/A year-over-year to $61200.0, compared with a TTM value of $61200.0 through Dec 2020, changed N/A, and an annual FY2020 reading of $61200.0, changed N/A over the prior year.
  • Non-Current Debt was $61200.0 for Q4 2020 at Ovid Therapeutics, roughly flat from $61200.0 in the prior quarter.
  • Across five years, Non-Current Debt topped out at $286562.0 in Q1 2020 and bottomed at $61200.0 in Q3 2020.